Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents

Depending on clinical circumstances ESAs may be offered to patients with chemotherapy-associated anemia whose cancer treatment is not curative in intent and whose hemoglobin has declined to <10 g/dL. Red blood cell transfusion is also an option, depending on the severity of the anemia or clinical circumstances. ( EB , H , S )